Loading company…
Westlake Omics provides proteomics and AI-based services for clinical research and drug development.
Founded in 2020 and based in Hangzhou, China, Westlake Omics provides proteomics, AIVC and multimodal data services for clinical research, diagnosis and drug development, along with related biotechnology kits. Founded by Professor Tiannan Guo of Westlake University, it has partnered with more than 100 universities, research institutes, hospitals and pharmaceutical companies. In July 2026, it received strategic investment from Rivercity Investment to support R&D and commercialization.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in